Afssaps wants further measures to cut French benzodiazepine use
This article was originally published in Scrip
Executive Summary
The French medicines agency Afssaps has outlined further measures to reduce the use of benzodiazepines in the country. The measures are detailed in a report on the consumption of the product class, which includes anti-anxiety medicines and sleeping pills.